Cargando…
Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
Clinical application of immune checkpoint inhibitors (CPIs) including nivolumab is expanding in the field of oncology treatment. Nivolumab is an anti-programmed death 1 protein (PD-1) antibody designed to augment an immunologic reaction against cancer cells. On the contrary, CPIs are known to cause...
Autores principales: | Ryuzaki, Masaki, Tokuyama, Hirobumi, Uchiyama, Kiyotaka, Nakaya, Hideaki, Hasegawa, Kazuhiro, Miyashita, Kazutoshi, Konishi, Kohnosuke, Hashiguchi, Akinori, Wakino, Shu, Itoh, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566467/ https://www.ncbi.nlm.nih.gov/pubmed/31223235 http://dx.doi.org/10.1177/1179547619853647 |
Ejemplares similares
-
Association of karyomegalic interstitial nephritis with focal segmental glomerulosclerosis
por: Chand, Momal Tara, et al.
Publicado: (2021) -
Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature
por: Isnard, Pierre, et al.
Publicado: (2016) -
A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis
por: Yamaguchi, Shintaro, et al.
Publicado: (2015) -
Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: A rare association
por: Radha, S., et al.
Publicado: (2014) -
Home-Based Exercise Program Ameliorates Renal Function Decline in Patients With CKD Stage 4
por: Adachi, Keika, et al.
Publicado: (2022)